Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars

No abstract is available for this paper.

• Publication year

  2016

• Venue

  British Journal of Pharmacology

• Publication date

  2016-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bph.13460PMID 26891034PMCID PMC4842923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars

  2016cited by this paper
• Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

  2015cited by this paper
• Experimental design and analysis and their reporting: new guidance for publication in BJP

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

  2015cited by this paper
• Lifespan and healthspan extension by resveratrol.

  2015cited by this paper
• SIRT1 and other sirtuins in metabolism.

  2014cited by this paper
• Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction

  2014influential reference
• Role of sirtuins in kidney disease

  2014cited by this paper
• Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.

  2014cited by this paper
• Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.

  2014cited by this paper
• Sirt1 Activation Ameliorates Renal Fibrosis by Inhibiting the TGF‐β/Smad3 Pathway

  2014influential reference
• SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential

  2013cited by this paper
• Effects of resveratrol on incisional wound healing in rats

  2013cited by this paper
• Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators

  2013cited by this paper
• Sirtuin deacetylases in neurodegenerative diseases of aging

  2013cited by this paper
• SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis.

  2013influential reference
• PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition

  2013cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

  2013cited by this paper
• The myofibroblast matrix: implications for tissue repair and fibrosis

  2013influential reference
• HDAC inhibitors in experimental liver and kidney fibrosis

  2013cited by this paper
• Protection against TGF-β1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring

  2013cited by this paper
• Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing

  2013cited by this paper
• Novel methods for the investigation of human hypertrophic scarring and other dermal fibrosis.

  2013cited by this paper
• Histone Deacetylase Inhibitor Reduces Hypertrophic Scarring in a Rabbit Ear Model

  2013cited by this paper
• Resveratrol inhibits fibrogenesis and induces apoptosis in keloid fibroblasts

  2013cited by this paper
• The role of the TGF-β family in wound healing, burns and scarring: a review.

  2012cited by this paper
• Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures.

  2012cited by this paper
• Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation.

  2012cited by this paper
• Multiple roles of class I HDACs in proliferation, differentiation, and development

  2012cited by this paper
• A systematic review of the quality of burn scar rating scales for clinical and research use.

  2012cited by this paper
• Effect of Resveratrol on Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats

  2012influential reference
• Extracellular matrix molecules implicated in hypertrophic and keloid scarring

  2012cited by this paper
• Wound Repair and Regeneration

  2012cited by this paper
• SIRT1 deacetylates RFX5 and antagonizes repression of collagen type I (COL1A2) transcription in smooth muscle cells.

  2012cited by this paper
• Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies

  2011cited by this paper
• Inhibition of PI3K Prevents the Proliferation and Differentiation of Human Lung Fibroblasts into Myofibroblasts: The Role of Class I P110 Isoforms

  2011cited by this paper
• Histone deacetylases as regulators of inflammation and immunity.

  2011cited by this paper
• Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.

  2011cited by this paper
• Resveratrol attenuates apoptosis of pulmonary microvascular endothelial cells induced by high shear stress and proinflammatory factors

  2011cited by this paper
• Mechanisms of pathological scarring: Role of myofibroblasts and current developments

  2011cited by this paper
• Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3.

  2010influential reference
• SIRT1 Transcription Is Decreased in Visceral Adipose Tissue of Morbidly Obese Patients with Severe Hepatic Steatosis

  2010cited by this paper
• Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid

  2010cited by this paper
• Effects of histone deacetylase inhibitors on rat mesangial cells.

  2010cited by this paper
• SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol.

  2010cited by this paper
• Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats

  2010influential reference
• Notch1 Deficiency Results in Decreased Inflammation during Wound Healing and Regulates Vascular Endothelial Growth Factor Receptor-1 and Inflammatory Cytokine Expression in Macrophages

  2010cited by this paper
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• EDA‐containing cellular fibronectin induces fibroblast differentiation through binding to α4β7 integrin receptor and MAPK/Erk 1/2‐dependent signaling

  2010cited by this paper
• The myofibroblast: paradigm for a mechanically active cell.

  2010influential reference
• Potential cellular and molecular causes of hypertrophic scar formation.

  2009cited by this paper
• Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats.

  2008cited by this paper
• Resveratrol prevents fibrosis, NF‐κB activation and TGF‐β increases induced by chronic CCl4 treatment in rats

  2008cited by this paper
• [Experimental research of correlation between anatomy structure of rabbit ear and creating hypertrophic scar animal model].

  2008cited by this paper
• Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin.

  2008cited by this paper
• Is There an Ideal Animal Model to Study Hypertrophic Scarring?

  2008cited by this paper
• Sirtuins in mammals: insights into their biological function.

  2007cited by this paper
• Cellular and molecular pathology of HTS: basis for treatment

  2007cited by this paper
• Heat shock-induced matrix metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop.

  2004cited by this paper
• Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

  2003cited by this paper
• How matrix metalloproteinases regulate cell behavior.

  2001cited by this paper
• A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture

  1999cited by this paper
• Acute and Chronic Animal Models for Excessive Dermal Scarring: Quantitative Studies

  1997cited by this paper
• Wound repair and regeneration

  1994cited by this paper

• Mitochondria in cutaneous health, disease, ageing and rejuvenation—the 3PM-guided mitochondria-centric dermatology

  2025cites this paper
• Epidermal stem cell derived exosomes-induced dedifferentiation of myofibroblasts inhibits scarring via the miR-203a-3p/PIK3CA axis

  2025cites this paper
• Microneedle drug delivery system based on hyaluronic acid for improving therapeutic efficiency of hypertrophic scars.

  2025cites this paper
• Sirtuins: Emergent Players in Tissue and Organ Regeneration

  2024cites this paper
• Natural products for the treatment of hypertrophic scars: Preclinical and clinical studies

  2024cites this paper
• Evidence of Potential Natural Products for the Management of Hypertrophic Scars

  2024cites this paper
• f*Healing with precision: A multi-functional hydrogel-bioactive glass dressing boosts infected wound recovery and enhances neurogenesis in the wound bed.

  2024cites this paper
• Applications of Exosomal miRNAs from Mesenchymal Stem Cells as Skin Boosters

  2024cites this paper
• Inhibition of phosphatidylinositol 3-kinase catalytic subunit alpha by miR-203a-3p reduces hypertrophic scar formation via phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway

  2024cites this paper
• Mechanoactive wound dressing using poly(N-isopropyl acrylamide) based hydrogels

  2024cites this paper
• The role of sirtuins in dermal fibroblast function

  2023cites this paper
• Sirt1 Overexpression Inhibits Fibrous Scar Formation and Improves Functional Recovery After Cerebral Ischemic Injury Through the Deacetylation of 14–3-3ζ

  2023cites this paper
• Photoactive Poly-L-Lysine gel with resveratrol-magnesium metal polyphenol network: A promising strategy for preventing tracheal anastomotic complications following surgery

  2023cites this paper
• HOX transcript antisense intergenic RNA is differentially expressed in hypertrophic scar tissues and regulates the biological function of scar fibroblasts through sponging miR-30a-5p

  2023cites this paper
• Insufficient SIRT1 in macrophages promotes oxidative stress and inflammation during scarring

  2023cites this paper
• Exosome from adipose-derived mesenchymal stem cells attenuates scar formation through microRNA-181a/SIRT1 axis.

  2023cites this paper
• A high-salt diet promotes hypertrophic scarring through TRPC3-mediated mitochondrial Ca2+ homeostasis dysfunction

  2023cites this paper
• Emerging Effects of Resveratrol on Wound Healing: A Comprehensive Review

  2022cites this paper
• The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes

  2022cites this paper
• Tauroursodeoxycholic Acid Decreases Keloid Formation by Reducing Endoplasmic Reticulum Stress as Implicated in the Pathogenesis of Keloid

  2021cites this paper
• The impact of resveratrol on skin wound healing, scarring, and aging

  2021influential citation
• Comparison of Primary Keloid Fibroblast Cultivation Methods and the Characteristics of Fibroblasts Cultured from Keloids, Keloid-surrounding Tissues, and Normal Skin Tissues

  2021cites this paper
• Fibrosis: Sirtuins at the checkpoints of myofibroblast differentiation and profibrotic activity

  2021influential citation
• An excellent antibacterial and high self-adhesive hydrogel can promote wound fully healing driven by its shrinkage under NIR.

  2021cites this paper
• Role of Resveratrol in Regulating Cutaneous Functions

  2020cites this paper
• Necrostatin‐1, RIP1/RIP3 inhibitor, relieves transforming growth factor β‐induced wound‐healing process in formation of hypertrophic scars

  2020cites this paper
• Resveratrol inhibits hypertrophic scars formation by activating autophagy via the miR-4654/Rheb axis

  2020cites this paper
• A review of epigenetic regulation in wound healing: Implications for the future of wound care

  2020cites this paper
• Novel Biomedical Functions of Surfactin A from Bacillus subtilis in Wound Healing Promotion and Scar Inhibition.

  2020cites this paper
• Activators of SIRT1 in wound repair: an animal model study

  2019cites this paper
• Biological approaches for hypertrophic scars

  2019cites this paper
• Resveratrol-loaded peptide-hydrogels inhibit scar formation in wound healing through suppressing inflammation

  2019cites this paper
• The Akt/FoxO/p27Kip1 axis contributes to the anti‐proliferation of pentoxifylline in hypertrophic scars

  2019cites this paper
• Epigenetic Regulation of Skin Wound Healing

  2018cites this paper
• Sirtuins and Accelerated Aging in Scleroderma

  2018cites this paper
• Epigenetic Regulation of Skin Development and Regeneration

  2018cites this paper
• Resveratrol Activated Sonic Hedgehog Signaling to Enhance Viability of NIH3T3 Cells in Vitro via Regulation of Sirt1

  2018cites this paper
• Keloid risk in patients with atopic dermatitis: a nationwide retrospective cohort study in Taiwan

  2018cites this paper
• Epidermal SIRT1 regulates inflammation, cell migration, and wound healing

  2017cites this paper
• Current Therapeutic Approach to Hypertrophic Scars

  2017cites this paper
• Sirtuins in Skin and Skin Cancers

  2017cites this paper
• Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway

  2016cites this paper
• Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars

  2016cites this paper
• The effects of Tubacin, a HDAC6 inhibitor on skin wound healing and its mechanism

  year unknowncites this paper